AI assistant
Sending…
Purple Biotech Ltd. — Capital/Financing Update 2017
Jul 15, 2017
7004_rns_2017-07-15_941262d4-348e-4db6-a255-9f294dcd8121.htm
Capital/Financing Update
Open in viewerOpens in your device viewer
_________ false
| ����� ����� ������ ��"� | 2 352 |
| KITOV PHARMACEUTICALS HOLDINGS LTD | |
| Corporation no: 520031238 | 10994 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C004 ( Public ) | Reported via MAGNA: | 15/07/2017 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2017-02-073617 | Time of broadcast: 22:06 21:57:28 |
Immediate report on other matterDon't use this form if there is more adequate one
| PROSPECTUS SUPPLEMENT (to Prospectus dated December 14, 2016) Filed Pursuant to Rule 424(b)(5) Registration No. 333-215037 ����� ������ ������ �� ������ ����� ������ ���� �� ����� ����"� ���� ������� ���� �� ����� ��� ����� ������ ����� ����� ����� 2017. ��� �� ���� ����� ���� �� ����� ����� ����� ������ ������ ���� �� ������ ������ ���� �� �����, ��� ����� ����� �� ����� ������ ���� ��� ����� �� ���� �����, �� �� ����, ����� �� ����� ���� ����� ����� ���� ����� ���� ������ �� ���� �������� ����� ����� ������ ��� ��� ����� �� ���� ����� |
| Attached file ProSupp_2017-07-13_isa.pdf |
| The submission by the Company to the Israel Securities Authority and the Tel Aviv Stock Exchange of a copy of a U.S. prospectus supplement originally filed by the Company with the United States Securities Exchange Commission pursuant to Rule 424(b)(5) filed should not be deemed an admission by the Company that such submission is required of the Company under the Securities Law 5728-1968 and the Securities Regulations (Periodic and Immediate Reports of Foreign Corporation)5761-2000, nor an admission by the Company that this submission is necessarily being delivered pursuant to the aforesaid laws and regulations. | |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 28/06/2017 |
| Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 , Israel Tel: 03-9333121 , 03-9311321 Fax: 03-5097196 | |
| E-mail address: [email protected] Company site: www.kitovpharma.com | |
| Previous names of reporting entity: MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD, | |
| Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: General Counsel & Company Secretary Name of Employer Company: | |
| Address: Menachem Begin St, Azrieli Towers Round Tower 132, Floor 23 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1 | |
| Israel |
More from Purple Biotech Ltd.
Report Publication Announcement
2026
May 15
Earnings Release
2026
May 15
Regulatory Filings
2026
Apr 27
Report Publication Announcement
2026
Apr 27
Report Publication Announcement
2026
Apr 23
Regulatory Filings
2026
Apr 23
Director's Dealing
2026
Apr 18
Director's Dealing
2026
Apr 18
Director's Dealing
2026
Apr 17
Director's Dealing
2026
Apr 17